To this end, WT and Lsp1 KO mice were subcutaneously challenged with B16 melanoma cells on day 0 followed by anti-PD-1 Ab or matched isotype control Ab on days 3, 6, 9 and 12 (figure 6C). The gene discussed is PDCD1; the disease is melanoma.